Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 fatty acids during adjuvant TS-1 chemotherapy after surgery for biliary tract cancer
jRCTs051180007Completed
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of omega-3-acid ethyl esters in biliary cancer, extrahepatic cholangiocarcinoma (eCCA), gallbladder cancer and 2 more. Primary endpoint: Completion rate of postoperative adjuvant chemotherapy with omega-3 fatty acids. Started Oct 2018; status: completed.
02
Drugs
omega-3-acid ethyl esters
03
Conditions
biliary cancerextrahepatic cholangiocarcinoma (eCCA)gallbladder cancerAmpullary cancer (AC)intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on jRCTs051180007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180007.